Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 152

1.

Echovirus type 6 transmission clusters and the role of environmental surveillance in early warning, the Netherlands, 2007 to 2016.

Monge S, Benschop K, Soetens L, Pijnacker R, Hahné S, Wallinga J, Duizer E.

Euro Surveill. 2018 Nov;23(45). doi: 10.2807/1560-7917.ES.2018.23.45.1800288.

PMID:
30424830
2.

Managing Invasive Aspergillosis in haematological patients in the era of resistance PCR and increasing triazole resistance: a modelling study of different strategies.

van de Peppel RJ, van der Beek MT, Visser LG, de Boer MGJ, Wallinga J.

Int J Antimicrob Agents. 2018 Nov 2. pii: S0924-8579(18)30313-3. doi: 10.1016/j.ijantimicag.2018.10.021. [Epub ahead of print]

PMID:
30395989
3.

Controls on late-Holocene drift-sand dynamics: The dominant role of human pressure in the Netherlands.

Pierik HJ, van Lanen RJ, Gouw-Bouman MT, Groenewoudt BJ, Wallinga J, Hoek WZ.

Holocene. 2018 Sep;28(9):1361-1381. doi: 10.1177/0959683618777052. Epub 2018 Jun 25.

4.

Influenza vaccination in patients with lung cancer receiving anti-programmed death receptor 1 immunotherapy does not induce immune-related adverse events.

Wijn DH, Groeneveld GH, Vollaard AM, Muller M, Wallinga J, Gelderblom H, Smit EF.

Eur J Cancer. 2018 Oct 24;104:182-187. doi: 10.1016/j.ejca.2018.09.012. [Epub ahead of print]

PMID:
30368069
5.

The impact of influenza vaccination on infection, hospitalisation and mortality in the Netherlands between 2003 and 2015.

Backer JA, Wallinga J, Meijer A, Donker GA, van der Hoek W, van Boven M.

Epidemics. 2018 Oct 11. pii: S1755-4365(17)30189-5. doi: 10.1016/j.epidem.2018.10.001. [Epub ahead of print]

6.

[Quantifying the impact of mass vaccination programmes on notified cases in the Netherlands].

Tulen AD, van Wijhe M, Korthals Altes H, McDonald SA, de Melker HE, Postma MJ, Wallinga J.

Ned Tijdschr Geneeskd. 2018 Sep 20;162. pii: D2983. Dutch.

PMID:
30306758
7.

The tip of the iceberg: incompleteness of measles reporting during a large outbreak in The Netherlands in 2013-2014.

Woudenberg T, Woonink F, Kerkhof J, Cox K, Ruijs WLM, van Binnendijk R, de Melker H, Hahné SJM, Wallinga J.

Epidemiol Infect. 2018 Oct 9:1-7. doi: 10.1017/S0950268818002698. [Epub ahead of print]

PMID:
30298798
8.

Metropolitan versus small-town influenza.

Wallinga J.

Science. 2018 Oct 5;362(6410):29-30. doi: 10.1126/science.aav1003. No abstract available.

PMID:
30287649
9.

S typhi Vi Capsular Polysaccharide Vaccine-Induced Humoral Immunity in Travelers with Immunosuppressive Therapy for Rheumatoid Disease.

von Asmuth EGJ, Brockhoff HJ, Wallinga J, Visser LG.

J Travel Med. 2018 Aug 22. doi: 10.1093/jtm/tay073. [Epub ahead of print]

PMID:
30137469
10.

Mycoplasma amphoriforme vs M. pneumoniae: similarities and differences between patient characteristics in a regional hospital in the Netherlands.

van Schaik ML, Patberg KW, Wallinga JG, Wolfhagen MJHM, Bruijnesteijn van Coppenraet LES.

J Med Microbiol. 2018 Sep;67(9):1348-1350. doi: 10.1099/jmm.0.000809. Epub 2018 Jul 27.

PMID:
30051803
11.

Inferring Pathogen Type Interactions Using Cross-sectional Prevalence Data: Opportunities and Pitfalls for Predicting Type Replacement.

Man I, Wallinga J, Bogaards JA.

Epidemiology. 2018 Sep;29(5):666-674. doi: 10.1097/EDE.0000000000000870.

PMID:
29923864
12.

Anatomy of Mississippi Delta growth and its implications for coastal restoration.

Chamberlain EL, Törnqvist TE, Shen Z, Mauz B, Wallinga J.

Sci Adv. 2018 Apr 11;4(4):eaar4740. doi: 10.1126/sciadv.aar4740. eCollection 2018 Apr.

13.

The Reduction of Measles Transmission During School Vacations.

Klinkenberg D, Hahné SJM, Woudenberg T, Wallinga J.

Epidemiology. 2018 Jul;29(4):562-570. doi: 10.1097/EDE.0000000000000841.

PMID:
29629940
14.

Benefits and Challenges in Using Seroprevalence Data to Inform Models for Measles and Rubella Elimination.

Winter AK, Martinez ME, Cutts FT, Moss WJ, Ferrari MJ, McKee A, Lessler J, Hayford K, Wallinga J, Metcalf CJE.

J Infect Dis. 2018 Jul 2;218(3):355-364. doi: 10.1093/infdis/jiy137.

15.

Quantifying the impact of mass vaccination programmes on notified cases in the Netherlands.

van Wijhe M, Tulen AD, Korthals Altes H, McDonald SA, de Melker HE, Postma MJ, Wallinga J.

Epidemiol Infect. 2018 Apr;146(6):716-722. doi: 10.1017/S0950268818000481. Epub 2018 Mar 14.

PMID:
29534768
16.

Years of life lost due to influenza-attributable mortality in older adults in the Netherlands: a competing risks approach.

McDonald SA, van Wijhe M, van Asten L, van der Hoek W, Wallinga J.

Am J Epidemiol. 2018 Feb 6. doi: 10.1093/aje/kwy021. [Epub ahead of print]

PMID:
29420681
17.

Estimating the Population-Level Effectiveness of Vaccination Programs in the Netherlands.

van Wijhe M, McDonald SA, de Melker HE, Postma MJ, Wallinga J.

Epidemiology. 2018 Mar;29(2):215-223. doi: 10.1097/EDE.0000000000000778.

PMID:
29087989
18.

Real-time Estimation of Epidemiologic Parameters from Contact Tracing Data During an Emerging Infectious Disease Outbreak.

Soetens L, Klinkenberg D, Swaan C, Hahné S, Wallinga J.

Epidemiology. 2018 Mar;29(2):230-236. doi: 10.1097/EDE.0000000000000776.

PMID:
29087987
19.

Variation in loss of immunity shapes influenza epidemics and the impact of vaccination.

Woolthuis RG, Wallinga J, van Boven M.

BMC Infect Dis. 2017 Sep 19;17(1):632. doi: 10.1186/s12879-017-2716-y.

20.

Dot map cartograms for detection of infectious disease outbreaks: an application to Q fever, the Netherlands and pertussis, Germany.

Soetens L, Hahné S, Wallinga J.

Euro Surveill. 2017 Jun 29;22(26). pii: 30562. doi: 10.2807/1560-7917.ES.2017.22.26.30562.

21.

Simultaneous inference of phylogenetic and transmission trees in infectious disease outbreaks.

Klinkenberg D, Backer JA, Didelot X, Colijn C, Wallinga J.

PLoS Comput Biol. 2017 May 18;13(5):e1005495. doi: 10.1371/journal.pcbi.1005495. eCollection 2017 May.

22.

Determinants of Rotavirus Transmission: A Lag Nonlinear Time Series Analysis.

van Gaalen RD, van de Kassteele J, Hahné SJM, Bruijning-Verhagen P, Wallinga J.

Epidemiology. 2017 Jul;28(4):503-513. doi: 10.1097/EDE.0000000000000654.

23.

Population effect of influenza vaccination under co-circulation of non-vaccine variants and the case for a bivalent A/H3N2 vaccine component.

Worby CJ, Wallinga J, Lipsitch M, Goldstein E.

Epidemics. 2017 Jun;19:74-82. doi: 10.1016/j.epidem.2017.02.008. Epub 2017 Feb 21.

24.

An Evidence Synthesis Approach to Estimating the Proportion of Influenza Among Influenza-like Illness Patients.

McDonald SA, van Boven M, Wallinga J.

Epidemiology. 2017 Jul;28(4):484-491. doi: 10.1097/EDE.0000000000000646.

PMID:
28252453
25.

Large measles epidemic in the Netherlands, May 2013 to March 2014: changing epidemiology.

Woudenberg T, van Binnendijk RS, Sanders EA, Wallinga J, de Melker HE, Ruijs WL, Hahné SJ.

Euro Surveill. 2017 Jan 19;22(3). pii: 30443. doi: 10.2807/1560-7917.ES.2017.22.3.30443.

26.

Mumps transmission in social networks: a cohort study.

Hahné S, Schurink T, Wallinga J, Kerkhof J, van der Sande M, van Binnendijk R, de Melker H.

BMC Infect Dis. 2017 Jan 10;17(1):56. doi: 10.1186/s12879-016-2135-5.

27.

The impact of individual-level heterogeneity on estimated infectious disease burden: a simulation study.

McDonald SA, Devleesschauwer B, Wallinga J.

Popul Health Metr. 2016 Dec 8;14:47.

28.

Spatiotemporal Analysis of the 2014 Ebola Epidemic in West Africa.

Backer JA, Wallinga J.

PLoS Comput Biol. 2016 Dec 8;12(12):e1005210. doi: 10.1371/journal.pcbi.1005210. eCollection 2016 Dec.

29.

The most efficient critical vaccination coverage and its equivalence with maximizing the herd effect.

Duijzer E, van Jaarsveld W, Wallinga J, Dekker R.

Math Biosci. 2016 Dec;282:68-81. doi: 10.1016/j.mbs.2016.09.017. Epub 2016 Oct 8.

PMID:
27729237
30.

Inferring R0 in emerging epidemics-the effect of common population structure is small.

Trapman P, Ball F, Dhersin JS, Tran VC, Wallinga J, Britton T.

J R Soc Interface. 2016 Aug;13(121). pii: 20160288. doi: 10.1098/rsif.2016.0288.

31.

Cost-Effectiveness of Dual Antimicrobial Therapy for Gonococcal Infections Among Men Who Have Sex With Men in the Netherlands.

Xiridou M, Lugnér A, de Vries HJ, van Bergen JE, Götz HM, van Benthem BH, Wallinga J, van der Sande MA.

Sex Transm Dis. 2016 Sep;43(9):542-8. doi: 10.1097/OLQ.0000000000000480.

PMID:
27513379
32.

Monitoring the spread of meticillin-resistant Staphylococcus aureus in The Netherlands from a reference laboratory perspective.

Donker T, Bosch T, Ypma RJ, Haenen AP, van Ballegooijen WM, Heck ME, Schouls LM, Wallinga J, Grundmann H.

J Hosp Infect. 2016 Aug;93(4):366-74. doi: 10.1016/j.jhin.2016.02.022. Epub 2016 Mar 15.

33.

Disease Burden of 32 Infectious Diseases in the Netherlands, 2007-2011.

van Lier A, McDonald SA, Bouwknegt M; EPI group, Kretzschmar ME, Havelaar AH, Mangen MJ, Wallinga J, de Melker HE.

PLoS One. 2016 Apr 20;11(4):e0153106. doi: 10.1371/journal.pone.0153106. eCollection 2016.

34.

The Role of Nursing Homes in the Spread of Antimicrobial Resistance Over the Healthcare Network.

van den Dool C, Haenen A, Leenstra T, Wallinga J.

Infect Control Hosp Epidemiol. 2016 Jul;37(7):761-7. doi: 10.1017/ice.2016.59. Epub 2016 Apr 7.

35.

End TB strategy: the need to reduce risk inequalities.

Gomes MG, Barreto ML, Glaziou P, Medley GF, Rodrigues LC, Wallinga J, Squire SB.

BMC Infect Dis. 2016 Mar 22;16:132. doi: 10.1186/s12879-016-1464-8.

36.

Effect of vaccination programmes on mortality burden among children and young adults in the Netherlands during the 20th century: a historical analysis.

van Wijhe M, McDonald SA, de Melker HE, Postma MJ, Wallinga J.

Lancet Infect Dis. 2016 May;16(5):592-598. doi: 10.1016/S1473-3099(16)00027-X. Epub 2016 Feb 10.

PMID:
26873665
37.

The impact of national vaccination policy changes on influenza incidence in the Netherlands.

McDonald SA, van Asten L, van der Hoek W, Donker GA, Wallinga J.

Influenza Other Respir Viruses. 2016 Mar;10(2):76-85. doi: 10.1111/irv.12366. Epub 2016 Feb 2.

38.

Distribution of Health Effects and Cost-effectiveness of Varicella Vaccination are Shaped by the Impact on Herpes Zoster.

van Lier A, Lugnér A, Opstelten W, Jochemsen P, Wallinga J, Schellevis F, Sanders E, de Melker H, van Boven M.

EBioMedicine. 2015 Aug 8;2(10):1494-9. doi: 10.1016/j.ebiom.2015.08.017. eCollection 2015 Oct.

39.

On the relative role of different age groups in influenza epidemics.

Worby CJ, Chaves SS, Wallinga J, Lipsitch M, Finelli L, Goldstein E.

Epidemics. 2015 Dec;13:10-16.

40.

[Analysis of patient flows: basis for regional control of antibiotic resistance].

Donker T, Ciccolini M, Wallinga J, Kluytmans JA, Grundmann H, Friedrich AW.

Ned Tijdschr Geneeskd. 2015;159:A8468. Dutch.

PMID:
26043250
41.

Direct benefit of vaccinating boys along with girls against oncogenic human papillomavirus: bayesian evidence synthesis.

Bogaards JA, Wallinga J, Brakenhoff RH, Meijer CJ, Berkhof J.

BMJ. 2015 May 12;350:h2016. doi: 10.1136/bmj.h2016.

42.

Joint modelling of serological and hospitalization data reveals that high levels of pre-existing immunity and school holidays shaped the influenza A pandemic of 2009 in the Netherlands.

Te Beest DE, Birrell PJ, Wallinga J, De Angelis D, van Boven M.

J R Soc Interface. 2015 Feb 6;12(103). pii: 20141244. doi: 10.1098/rsif.2014.1244.

43.

Homo erectus at Trinil on Java used shells for tool production and engraving.

Joordens JC, d'Errico F, Wesselingh FP, Munro S, de Vos J, Wallinga J, Ankjærgaard C, Reimann T, Wijbrans JR, Kuiper KF, Mücher HJ, Coqueugniot H, Prié V, Joosten I, van Os B, Schulp AS, Panuel M, van der Haas V, Lustenhouwer W, Reijmer JJ, Roebroeks W.

Nature. 2015 Feb 12;518(7538):228-31. doi: 10.1038/nature13962. Epub 2014 Dec 3.

PMID:
25470048
44.

Discrimination of influenza infection (A/2009 H1N1) from prior exposure by antibody protein microarray analysis.

te Beest D, de Bruin E, Imholz S, Wallinga J, Teunis P, Koopmans M, van Boven M.

PLoS One. 2014 Nov 18;9(11):e113021. doi: 10.1371/journal.pone.0113021. eCollection 2014. Erratum in: PLoS One. 2015;10(2):e0118047.

45.

Estimating seroprevalence of human papillomavirus type 16 using a mixture model with smoothed age-dependent mixing proportions.

Vink MA, van de Kassteele J, Wallinga J, Teunis PF, Bogaards JA.

Epidemiology. 2015 Jan;26(1):8-16. doi: 10.1097/EDE.0000000000000196.

PMID:
25380503
46.

Exceptionally low rotavirus incidence in the Netherlands in 2013/14 in the absence of rotavirus vaccination.

Hahné S, Hooiveld M, Vennema H, van Ginkel A, de Melker H, Wallinga J, van Pelt W, Bruijning-Verhagen P.

Euro Surveill. 2014 Oct 30;19(43). pii: 20945.

47.

Serial intervals of respiratory infectious diseases: a systematic review and analysis.

Vink MA, Bootsma MC, Wallinga J.

Am J Epidemiol. 2014 Nov 1;180(9):865-75. doi: 10.1093/aje/kwu209. Epub 2014 Oct 7. Review.

PMID:
25294601
48.

Public health measures to control the spread of antimicrobial resistance in Neisseria gonorrhoeae in men who have sex with men.

Xiridou M, Soetens LC, Koedijk FD, VAN DER Sande MA, Wallinga J.

Epidemiol Infect. 2015 Jun;143(8):1575-84. doi: 10.1017/S0950268814002519. Epub 2014 Oct 2.

PMID:
25275435
49.

OutbreakTools: a new platform for disease outbreak analysis using the R software.

Jombart T, Aanensen DM, Baguelin M, Birrell P, Cauchemez S, Camacho A, Colijn C, Collins C, Cori A, Didelot X, Fraser C, Frost S, Hens N, Hugues J, Höhle M, Opatowski L, Rambaut A, Ratmann O, Soubeyrand S, Suchard MA, Wallinga J, Ypma R, Ferguson N.

Epidemics. 2014 Jun;7:28-34. doi: 10.1016/j.epidem.2014.04.003. Epub 2014 Apr 18.

50.

Estimation of the serial interval of pertussis in Dutch households.

Te Beest DE, Henderson D, van der Maas NA, de Greeff SC, Wallinga J, Mooi FR, van Boven M.

Epidemics. 2014 Jun;7:1-6. doi: 10.1016/j.epidem.2014.02.001. Epub 2014 Feb 18.

Supplemental Content

Loading ...
Support Center